Instil Bio

Price & Volume

Stats

52W Range	$5.67-$42.79
Market Cap	$48.3M
Shares Short	544,356

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$138,000
Diluted EPS	-$11.35

News

Yahoo Finance • 5 months ago

Instil Bio Non-GAAP EPS of -$3.24

Yahoo Finance • 5 months ago

Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Yahoo Finance • 5 months ago

ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China

Yahoo Finance • 6 months ago

Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors

About

CEO	Mr. Bronson Crouch
CFO	Dr. Sandeep Laumas M.D.
Address	3963 Maple Avenue, Dallas, TX, United States, 75219
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	14